Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Intarcia’s Exenatide Implant Rejected Again As US FDA Denies Comparative Safety Argument
Aug 23 2024
•
By
Sue Sutter
FDA has closed the door to approval of Intarcia's ITCA 650. • Source: Shutterstock
More from Product Reviews
More from Pink Sheet